These outcomes, together with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 assist the strategy of targeting ACKR3 as a singular technique to modulate the opioid procedure, which could open new therapeutic avenues for opioid-linked Diseases. In addition to the described previously https://wesleyw370zzu1.blogscribble.com/profile